Saavedra, Kristel Jane S.

HRN: 18-16-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2026
MUPIROCIN 2%, 15G (TUBE)
03/31/2026
04/07/2026
TOPICAL
2%
BID
S/P CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines